CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-07 | Greene Barry E President | Exercise or conversion · Stock Option (right to buy) | −22,265 | 44,530 | ||
| 2020-07-01 | HAMBURG MARGARET A Director | Grant or award · Stock Option (right to buy) | +4,581 | 4,581 | ||
| 2020-07-01 | BONNEY MICHAEL W Director | Grant or award · Stock Option (right to buy) | +4,581 | 4,581 | ||
| 2020-07-01 | Ausiello Dennis A Director | Grant or award · Stock Option (right to buy) | +4,581 | 4,581 | ||
| 2020-07-01 | Fanucci Marsha Director | Grant or award · Stock Option (right to buy) | +4,581 | 4,581 | ||
| 2020-07-01 | PAUL STEVEN M Director | Grant or award · Stock Option (right to buy) | +4,581 | 4,581 | ||
| 2020-07-01 | SHARP PHILLIP A Director | Grant or award · Stock Option (right to buy) | +4,581 | 4,581 | ||
| 2020-07-01 | SCHULMAN AMY W Director | Grant or award · Stock Option (right to buy) | +4,581 | 4,581 | ||
| 2020-07-01 | Reitan Colleen F Director | Grant or award · Stock Option (right to buy) | +4,581 | 4,581 | ||
| 2020-07-01 | PYOTT DAVID E I Director | Grant or award · Stock Option (right to buy) | +4,581 | 4,581 | ||
| 2020-06-22 | Vaishnaw Akshay President, R&D | Exercise or conversion | +970 | $42.22 | $41K | 15,089 |
| 2020-06-22 | Vaishnaw Akshay President, R&D | Sale | −178 | $148.48 | $26K | 14,911 |
| 2020-06-22 | Vaishnaw Akshay President, R&D | Sale | −83 | $149.09 | $12K | 14,828 |
| 2020-06-22 | Vaishnaw Akshay President, R&D | Sale | −180 | $150.34 | $27K | 14,648 |
| 2020-06-22 | Vaishnaw Akshay President, R&D | Sale | −334 | $152.22 | $51K | 14,314 |
| 2020-06-22 | Vaishnaw Akshay President, R&D | Sale | −195 | $152.97 | $30K | 14,119 |
| 2020-06-22 | Vaishnaw Akshay President, R&D | Exercise or conversion · Stock Option (right to buy) | −970 | 4,309 | ||
| 2020-05-20 | MARAGANORE JOHN Chief Executive Officer | Exercise or conversion | +34,765 | $9.14 | $318K | 232,354 |
| 2020-05-20 | MARAGANORE JOHN Chief Executive Officer | Sale | −13,437 | $142.51 | $1.9M | 218,917 |
| 2020-05-20 | MARAGANORE JOHN Chief Executive Officer | Sale | −16,315 | $143.46 | $2.3M | 202,602 |
Page 76 of 80 · 1,590 trades